GE HealthCare Technologies GEHC
NASDAQ GEHC
$74.99 +0.37 (+0.50%)
At close: Aug 20, 2026 · 1:16 PM UTC

GE HealthCare Technologies (GEHC) Other Non-Current Liabilities (2022 - 2026)

GE HealthCare Technologies' (GEHC) quarterly Other Non-Current Liabilities came in at $2.1 billion in Q2 2026, up 6.38% YoY from $2.0 billion in Q2 2025, and up 5.86% on a QoQ basis from $2.0 billion in Q1 2026.

GE HealthCare Technologies (GEHC) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends

GE HealthCare Technologies (GEHC) has 5 years of Other Non-Current Liabilities data on file, last reported at $2.1 billion in Q2 2026.

  • Quarterly Other Non-Current Liabilities rose 6.38% year-over-year to $2.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.1 billion (up 6.38% YoY) and the FY2025 annual result came in at $2.1 billion, up 14.76% from the prior year.
  • Other Non-Current Liabilities advanced to $2.1 billion in Q2 2026, from $2.0 billion in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $2.1 billion in Q2 2026 to a low of $1.6 billion in Q4 2022.
  • A 5-year average of $1.9 billion and a median of $1.9 billion in 2023 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Other Non-Current Liabilities advanced 17.09% — and 2024, when it dropped 6.75%.
  • Tracing GEHC's Other Non-Current Liabilities over 5 years: stood at $1.6 billion in 2022, then increased by 17.09% to $1.9 billion in 2023, then retreated by 4.32% to $1.8 billion in 2024, then climbed by 14.76% to $2.1 billion in 2025, then rose by 3.49% to $2.1 billion in 2026.
  • The last three Other Non-Current Liabilities figures came in at $2.1 billion (Q2 2026), $2.0 billion (Q1 2026), and $2.1 billion (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.24 Bn 193.64 Bn 7.27 Bn
2 Stryker 128.63 Bn 125.15 Bn 4.50 Bn
3 Medtronic 119.19 Bn 109.97 Bn 6.41 Bn
4 Boston Scientific 73.51 Bn 72.97 Bn 3.85 Bn
5 Edwards Lifesciences 52.11 Bn 47.85 Bn 1.35 Bn
6 Dexcom 34.64 Bn 32.70 Bn 830.00 Mn
7 GE HealthCare Technologies 34.01 Bn 31.90 Bn 2.18 Bn
8 Koninklijke Philips 26.40 Bn 23.08 Bn 4.55 Bn
9 Steris 23.14 Bn 22.65 Bn 684.20 Mn
10 Zimmer Biomet Holdings 19.32 Bn 18.91 Bn 1.54 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.13 Bn
Mar 31, 2026 2.02 Bn
Dec 31, 2025 2.06 Bn
Sep 30, 2025 2.10 Bn
Jun 30, 2025 2.01 Bn
Mar 31, 2025 1.84 Bn
Dec 31, 2024 1.80 Bn
Sep 30, 2024 1.92 Bn
Jun 30, 2024 1.80 Bn
Mar 31, 2024 1.81 Bn
Dec 31, 2023 1.88 Bn
Sep 30, 2023 1.83 Bn
Jun 30, 2023 1.93 Bn
Mar 31, 2023 1.83 Bn
Dec 31, 2022 1.60 Bn